Các bài viết có thể truy cập công khai - Dominick AngiolilloTìm hiểu thêm
Không có ở bất kỳ nơi nào: 26
Advances in antiplatelet therapy: agents in clinical development
DJ Angiolillo, DL Bhatt, PA Gurbel, LK Jennings
The American journal of cardiology 103 (3), 40A-51A, 2009
Các cơ quan ủy nhiệm: US National Institutes of Health
P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention
D Capodanno, U Baber, DL Bhatt, JP Collet, G Dangas, F Franchi, ...
Nature Reviews Cardiology 19 (12), 829-844, 2022
Các cơ quan ủy nhiệm: US National Institutes of Health
Age-and weight-adapted dose of prasugrel versus standard dose of ticagrelor in patients with acute coronary syndromes: results from a randomized trial
M Menichelli, FJ Neumann, G Ndrepepa, K Mayer, J Wöhrle, ...
Annals of Internal Medicine 173 (6), 436-444, 2020
Các cơ quan ủy nhiệm: German Research Foundation
Revacept, a novel inhibitor of platelet adhesion, in patients undergoing elective PCI—design and rationale of the randomized ISAR-PLASTER trial
S Schüpke, R Hein-Rothweiler, K Mayer, M Janisch, D Sibbing, ...
Thrombosis and Haemostasis 119 (09), 1539-1545, 2019
Các cơ quan ủy nhiệm: German Research Foundation, Federal Ministry of Education and Research, Germany
The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein AI [human]), an intravenous formulation of plasma-derived apolipoprotein AI, among …
CM Gibson, M Kerneis, MK Yee, Y Daaboul, S Korjian, AP Mehr, P Tricoci, ...
American heart journal 208, 81-90, 2019
Các cơ quan ủy nhiệm: US National Institutes of Health
Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials
DJ Angiolillo, DL Bhatt, PG Steg, GW Stone, HD White, CM Gibson, ...
Journal of thrombosis and thrombolysis 40, 317-322, 2015
Các cơ quan ủy nhiệm: US National Institutes of Health, National Institute of Health and Medical …
Diabetes mellitus, CYP2C19 genotype, and response to escalating doses of clopidogrel
ET Carreras, W Hochholzer, AL Frelinger III, F Nordio, ML O’Donoghue, ...
Thrombosis and haemostasis 116 (07), 69-77, 2016
Các cơ quan ủy nhiệm: US National Institutes of Health
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel
F Franchi, F Rollini, JR Cho, R King, F Phoenix, M Bhatti, C DeGroat, ...
Thrombosis and haemostasis 115 (03), 622-631, 2016
Các cơ quan ủy nhiệm: British Heart Foundation
Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery disease
S Romano, S Buccheri, R Mehran, DJ Angiolillo, D Capodanno
Expert opinion on drug safety 17 (10), 1041-1052, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
CSL112, a reconstituted, infusible, plasma-derived apolipoprotein AI: safety and tolerability profiles and implications for management in patients with myocardial infarction
D Capodanno, R Mehran, CM Gibson, DJ Angiolillo
Expert opinion on investigational drugs 27 (12), 997-1005, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
Personalised antiplatelet therapies for coronary artery disease: what the future holds
D Capodanno, DJ Angiolillo
European Heart Journal 44 (32), 3059-3072, 2023
Các cơ quan ủy nhiệm: Government of Italy
The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shifts
JY Moon, F Franchi, F Rollini, DJ Angiolillo
Expert Review of Hematology 11 (1), 5-12, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus
A Tello-Montoliu, JL Ferreiro, MK Kodali, M Ueno, SD Tomasello, F Rollini, ...
Journal of thrombosis and thrombolysis 36, 14-17, 2013
Các cơ quan ủy nhiệm: Government of Spain
Aspirin for primary prevention of cardiovascular disease
D Capodanno, DJ Angiolillo
The Lancet 392 (10152), 988-990, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
Systemic inflammatory status is associated with increased platelet reactivity in the early period after acute coronary syndromes
S Cornara, G Crimi, A Somaschini, M Cattaneo, DJ Angiolillo, T Palmerini, ...
Platelets 29 (5), 528-530, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties
J Ten Berg, B Rocca, DJ Angiolillo, K Hayashida
European Heart Journal 43 (44), 4616-4634, 2022
Các cơ quan ủy nhiệm: Netherlands Organisation for Health Research and Development
Impact of aspirin dose on adenosine diphosphate-mediated platelet activities
A Tello-Montoliu, E Thano, F Rollini, R Patel, RE Wilson, A Muñiz-Lozano, ...
Thrombosis and haemostasis 110 (10), 777-784, 2013
Các cơ quan ủy nhiệm: Government of Spain
Ticagrelor versus clopidogrel for recovery of vascular function immediately after successful chronic coronary total occlusion recanalization: a randomized clinical trial
S Brugaletta, J Gomez-Lara, J Caballero, L Ortega-Paz, L Teruel, ...
American Heart Journal 204, 205-209, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
Vascular access and antithrombotic therapy in patients with acute coronary syndrome
DJ Angiolillo
The Lancet 392 (10150), 801-802, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease
AH Talasaz, P Sadeghipour, L Ortega-Paz, H Kakavand, ...
Nature Reviews Cardiology 21 (8), 574-592, 2024
Các cơ quan ủy nhiệm: European Commission
Chương trình máy tính sẽ tự động xác định thông tin xuất bản và thông tin về nhà tài trợ